Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BNS003 for Swelling in Venous Insufficiency
NCT02211898Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2004
- Primary completion
- Jan 2005
- Modality
- Small Molecules
01
Overview
Phase 3, single-arm trial of BNS003 in chronic venous insufficiency (CVI), sponsored by Boehringer Ingelheim. Primary endpoints: Global improvement on a five point scale at week 12 and Number of patients with adverse drug reactions. Started Jul 2004; status: completed.
02
Drugs
BNS003
03
Conditions
chronic venous insufficiency (CVI)
Beyond the preview
Go deeper on NCT02211898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02211898.